logo
Wrong email address or username
Wrong email address or username
Incorrect verification code
back to top
Search tags: anemia
Load new posts () and activity
Like Reblog Comment
text 2021-07-13 16:16
PHYSIOLOGY AND PATHOLOGY OF SICKLE CELL ANEMIA

The human body is created astonishingly. Every part and system is precise and perfect in performing its desired functions. Blood is one of the core bases of life. If the blood functioning is disrupted due to any reason, then the consequences can be very severe, chronic, and sometimes fatal. The associated blood diseases sometimes tend to follow a genetic or inherited pattern. The blood abnormality we are about to discuss today is strictly genetic and can be fatal at times.

 

WHAT IS SICKLE CELL ANEMIA:

 

Sickle Cell Anemia or Sickle Cell Disease (SCD) is a blood disease following a genetic trial. In this disease, the regular disc shape of the Erythrocytes becomes abnormal sickle or crescent-shaped. The erythrocytes, due to irregular shape transformation, find it difficult to pass the blood vessels. It also affects the oxygen-carrying capacity of the Red Blood Corpuscles.

The sickle-shaped Erythrocytes become rigid and prone to getting stuck in the blood vessels causing cytological and histological damages within the body.

 

SYMPTOMS OF SICKLE CELL ANEMIA:

 

Every medical abnormality is followed by sure signs and symptoms that help in diagnosing the disease. Following the same, the prime symptoms that help in identifying sickle cell anemia are given below:

 

  • Hemolysis: 

Rapid destruction of erythrocytes. 

 

  • Optic Dysfunction:

The patient is observed to suffer from an incurable vision problem as the tiny optic vessels get plugged, causing damages to the retina and the vision automatically.

 

  • Adema:

Swelling and over swelling of hands and feet mainly. In cases, swelling is observed on the whole body.

 

  • Jaundice:

The eyes and skin turn yellow, followed by weakness.

 

  • Frequent Infections

The patient suffers from infection frequently, which ends up weakening the immune system of the patient. Damage of the spleen causes fatal and chronic conditions in the patient.

 

  • Anemia:

Due to the rapid destruction of the erythrocytes, the patient suffers from anemic critical conditions. It is one of the significant symptoms of sickle cell anemia.

 

CAUSES OF SICKLE CELL ANEMIA:

 

  • Genetic Cause:

Sickle cell anemia is caused by the mutation in the gene that is responsible for carrying the relevant genetic information about the production of hemoglobin (the iron-rich compound that gives the blood its red color, enabling the erythrocytes to carry the oxygen from the lungs throughout the human body.

 

  • Congenital Cause:

The transferring of the mutated gene is also in the body of the fetus,

 

MEDICAL COMPLICATIONS OF SICKLE CELL ANEMIA: 

 

Acute Chest Syndrome:

The life-threatening condition in which the sickle cell erythrocytes block the blood vessels of the lungs causing difficulty in breathing. Sometimes it may lead to Pneumonitis (inflammation in the lungs).

 

Leg Ulcer:

Swelling is observed on the entire body, including the legs and hands particularly. This condition is termed a leg ulcer.

 

Organ damage:

Lack of oxygen-rich blood in the organs causes dysfunction of the organs, including kidney, liver, spleen, etc. In many observed cases, the deficiency of oxygen-rich blood had been fatal to the patients. 

 

Eye abnormalities:

Blockage in the eye vessels of the body can cause severe damages to the visions and visuals of the patient.

 

Neurological Complications:

Oxygen-Rich blood is most important for the proper functioning of our brain. The deficiency of oxygen can cause severe damages to the brain resulting in epilepsy, seizures, and strokes. 

 

Sometimes the patient is observed to slip into a comma. All of these abnormalities are caused by the blockage of the brain.

 

Delayed Growth:

The retardation of physical growth is observed in the children specifically. It is a possibility that the children face delayed development in their childhood, but they might retain their growth usually in their adulthood.

 

Sex maturation is also an evidential complication observed as a consequence of sickle cell anemia.

 

LABORATORY DIAGNOSIS:

Blood Tests:

As sickle cell anemia is a blood-associated disease, so blood diagnosis is the best cheap and reliable test to diagnose the condition.

 

  • CBC or Complete Blood Count:

 

Helps in estimating the count of erythrocytes in the blood. Decreased amount of RBCs proves that the patient is facing some severe hemolytic effects.

 

  • Blood Smears:

 

The formation of blood smears aids in estimating the average and contracted number of cells circulating in the blood.

 

  • Sickle solubility test:

 

This test helps graph the concentration of hemoglobin (Hb) in the blood. Decreased concentration will increase the possibility of the disease.

 

TREATMENT:

 

Bone Marrow Transplant:

 

Sickle cell anemia is difficult to treat with drugs and medications. The most effective way to cure this disorder of blood is a bone marrow transplant. As the disease causes hemolysis (destruction of RBCs), bone marrow transplant will aid in the formation of new blood cells decreasing the destructions of the cells.

 

Medications to increase fetal hemoglobin:

 

Droxia and Hydrea help in increasing the fetal hemoglobin in the body.

Sickle cell anemia can be fatal and can cause death if not treated on time. You can get many resources like Researchomatic, Wikipedia, etc from where you can get more details about the said topic.

Source: www.researchomatic.com/sickle-cell-anemia-icon-of-evolution-158753.html
Like Reblog Comment
text 2020-04-02 14:22
Anemia Therapeutics Market By Product Type, By Application, By Region: Industry Analysis, Market Share, Revenue Opportunity, Competitive Analysis and Forecast 2020-2027.

Anemia Therapeutics Market is estimated to value over USD xx billion by 2027 end and register a CAGR of over xx% during the forecast period 2020 to 2027.

The report initiates from the outline of business surroundings and explains the commercial summary of chain structure. Moreover, it analyses forecast By Product, By Application, by Region and  Anemia Therapeutics market Trends.

Additionally, this report illustrates the corporate profiles and situation of competitive landscape amongst numerous associated corporations including the analysis of market evaluation and options associated with the worth chain. This report provides valuable insights on the general market profit through a profit graph, an in-depth SWOT analysis of the market trends alongside the regional proliferation of this business vertical.

Request a Sample Report @  https://www.futurewiseresearch.com/request-sample.aspx?id=4155&page=requestsample

Market Segmentation:

This Market is divided By Product, By Application and By Region.

Regionally, the worldwide  Anemia Therapeutics market is fragmented as North America, Europe, Asia Pacific and also the rest of the world.

 

Key Market Players:

  • Galenica
  • Pharmacosmos
  • Bayer
  • AMAG Pharmaceuticals
  • Daiichi Sankyo
  • GlaxoSmithKline
  • Novartis
  • Pieris Pharmaceuticals
  • Acceleron Pharma
  • Sanofi

 

Note: The list of the key players are going to be updated with the most recent market scenario and trends)

Purchase a Copy & Ask For Discount: https://www.futurewiseresearch.com/request-sample.aspx?id=4155&page=askfordiscount

FutureWise Key Takeaways:

  •       Growth prospects
  •       SWOT analysis
  •       Key trends
  •       Key data-points touching market growth

Competitive Landscape:

  •       Tier 1 players- well-established companies in the market accounting a major market share  
  •       Tier 2 players 
  •       Rapidly growing players
  •       New Entrants

Objectives of the Study:

  •       To offer with a complete analysis on the  Anemia Therapeutics market By Product, by Application and by region.
  •       To cater comprehensive data on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  •       To measure and forecast micro-markets and also the overall market
  •       To predict the market size, in key regions — North America, Europe, Asia Pacific and rest of the world
  •       To record and evaluate the competitive landscape mapping - product launches, technological advancements, mergers and expansions

Browse Corresponding Healthcare Market Research Reports Consulting:

  •       Invisible Braces Market is forecasted to value over USD xx billion by 2027 end and register a CAGR of xx% from the forecast period 2020-2027.
  •     Non-PVC IV Bag Market is projected to achieve significant growth by the end of the forecast period as per the research study conducted by FutureWise research analysts.

Flexible Delivery Model:

  •       We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  •       The customization services offered are free of charge with purchase of any license of the report.
  •       You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

 

About FutureWise Research:

We specialize in high-growth niche market research, assuring flexibility, agility and customized solutions for our clients. Through in-depth market insights and consultancy, we present our clients with the tools they need to be at the forefront of their industry – a position secured for far more than the near future.

 

Company Name: FutureWise Research

Contact Person:  VinayThaploo

Email: sales@futurewiseresearch.com

Phone: +44 141 628 9353 / +1 347 709 4931

City:  Leeds

Country:  United Kingdom

Website: www.futurewiseresearch.com

 

Like Reblog Comment
text 2019-12-06 09:33
Anemia Therapeutics Market Global Trends, Market Share, Industry Size, Growth, Opportunities, and Market Forecast 2019 to 2026

Anemia Therapeutics Market is estimated to value over USD xx billion by 2026 end and register a CAGR of over xx% during the forecast period 2019 to 2026.

The report initiates from the outline of business surroundings and explains the commercial summary of chain structure. moreover, it analyses forecast of Anemia Therapeutics By Product type, By Application, By Region and Anemia Therapeutics market size.

Additionally, this report illustrates the corporate profiles and situation of competitive landscape amongst numerous associated corporations including the analysis of market evaluation and options associated with the worth chain. This report provides valuable insights on the general market profit through a profit graph, an in depth SWOT analysis of the Anemia Therapeutics market trends along side the regional proliferation of this business vertical.

Request a Sample Report @ https://www.futurewiseresearch.com/request-sample.aspx?id=4155&page=requestsample

Anemia Therapeutics Market Segmentation:

The Anemia Therapeutics Market is divided By Product type, By Application and By Region.

Regionally, the worldwide Anemia Therapeutics market is fragmented as North America, Europe, Asia Pacific and also the rest of the world.

 

Key Market Players:

Major market players enclosed within the Anemia Therapeutics market are Galenica, Pharmacosmos, Bayer, AMAG Pharmaceuticals, Daiichi Sankyo, GlaxoSmithKline, Novartis, Pieris Pharmaceuticals, Acceleron Pharma and Sanofi.

(Note: The list of the key players are going to be updated with the most recent market scenario and trends)

Purchase a Copy & Ask For Discount: https://www.futurewiseresearch.com/request-sample.aspx?id=4155&page=askfordiscount

FutureWise Key Takeaways:

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points touching market growth

Competitive Landscape:

  • Tier 1 players- well-established companies in the market accounting a major market share  
  • Tier 2 players 
  • Rapidly growing players
  • New Entrants

 

Objectives of the Study:

  • To offer with an complete analysis on the Anemia Therapeutics market By Product type, By Region and By Application
  • To cater comprehensive data on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To measure and forecast micro-markets and also the overall market
  • To predict the market size, in key regions — North America, Europe, Asia Pacific and rest of the world
  • To record and evaluate the competitive landscape mapping - product launches, technological advancements, mergers and expansions

 

Browse Corresponding Healthcare Market Research Reports & Consulting

 

Flexible Delivery Model:

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization services offered are free of charge with purchase of any license of the report.
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

 

About FutureWise Research:

We specialize in high-growth niche markets, assuring flexibility, agility and customized solutions for our clients. Through in-depth market insights and consultancy, we present our clients with the tools they need to be at the forefront of their industry – a position secured for far more than the near future.

 

Company Name: FutureWise Research

Contact Person:  Vinay Thaploo

Email: sales@futurewiseresearch.com

Phone: +44 141 628 9353 / +1 347 709 4931

City:  Leeds

Country:  United Kingdom

Website: www.futurewiseresearch.com

Like Reblog Comment
text 2019-03-06 07:25
Sickle Cell Anemia Therapeutics Market is Expected to Gain Popularity Across the Globe by 2026

A drastic reduction in the total red blood cells or RBC count or hemoglobin is known as anemia. It can be defined as the inability to carry optimum amount of oxygen by the blood. Sickle-cell diseases (SCD) are types of blood disorders which are usually inherited genetically. One of the common types of SCDs is the sickle-cell anemia or SCA. It essentially gives rise to an irregularity in hemoglobin, the protein that carries oxygen in the blood. Hemoglobin is found typically in the red blood cells of the body. As a result a sickle-like shaped cell is formed under certain conditions.


Tribulations in sickle cell disease usually start to take shape at a very early age (within the first year of birth). This might lead to various health problems including pain attacks also known as the sickle-cell crisis, swelling in the limbs, microbial infections, and in certain cases, stroke. Chronic pain may develop with age. Sickle-cell diseases arise when an individual inherits abnormal copies of hemoglobin gene from each parent. Click To Read More On Sickle Cell Anemia Therapeutics Market.


According to Center for Disease Control and Prevention, as of 2016, around 100,000 people in the U.S. are affected by sickle cell diseases or SCDs. Sickle cell diseases are very common among black or African Americans. Around 1 in 13 babies belonging to the race are born with sickle cell diseases. Growing prevalence of the disease will give rise to an increased demand for sickle cell disease prevention and cure, thereby augmenting the growth of the overall sickle cell anemia therapeutics market.


The National Center for Biotechnology Information says that sickle cell anemia is one of the most common hereditary hematological diseases among humans. Annually, around 250,000 children are born with the disease and it is among the most occurring epidemiological genetic diseases worldwide. Governments around the world, especially in Africa are taking initiatives to prevent and cure the disease as a result of which, huge investments on this field are expected in the coming years. This in turn will encourage the manufacturers around the world to manufacture in large quantities to meet the unmet demand thereby propelling the growth of the sickle cell anemia therapeutics market.


There is a growing need of early detection and prevention of curable diseases especially among the adults. This is going to be a key opportunity in the market as the percentage of adult population is increasing on a daily basis owing to the rise in life expectancy among the global population. Additionally, the demand for safe and efficacious treatments is gaining prevalence in the market. This factor coupled with unmet medical needs among the patients will fuel the growth of the global sickle cell anemia therapeutics industry.


Ask For Sample Copy Of This Business Research Report : https://www.coherentmarketinsights.com/insight/request-sample/161


Manufacturers around the world are competing on the availability of technologically advanced drugs for the treatment of sickle cell anemia. Key players operating in the global sickle cell anemia therapeutics market are Bristol-Myers Squibb, GlycoMimetics, Pfizer,Anthera Pharmaceuticals Inc., GlycoMimetics, Inc., Eli Lilly, and Mast Therapeutics.Some of the other manufacturers are Daiichi Sankyo, Novartis Pharmaceuticals, Bluebird Bio, HemaQuest Pharmaceuticals Inc., Emmaus Medical, HemaQuest Pharmaceuticals, Baxter, and Merck Sharp & Dohme.


Increasing occurrence of the disease especially in the Africa region will drive the sickle cell anemia therapeutics market


According to the World Health Organization, around 5% of the population around the globe carries the gene for the sickle cell disease. This percentage is as high as 25% in some of the regions around the world. According to the same report, WHO has estimated that the occurrence of sickle cell disease is highest in the African region. To meet this crisis of high prevalence of the disease, WHO’s governing bodies has taken initiatives to address the same. Moreover, according to PLOS Medicine, the occurrence of sickle cell anemia is likely to rise by around 30% by 2050, especially in the sub-Saharan Africa. This rise in demand will eventually push the global sickle cell anemia therapeutics market into a positive growth trajectory over the course of the forecast period (2016-2024).


About Coherent Market Insights:


Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.


Contact Us:


Mr. Shah
Coherent Market Insights
1001 4th Ave, 
#3200 
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com

More posts
Your Dashboard view:
Need help?